
<!doctype html><html lang="en"> <head><meta charset="utf-8"> 
<title>s800 inconsistencies</title> 
<style>

.gray { background-color:rgba(125, 125, 125, 0.5); } 
.orange { background-color:rgba(210, 180, 180, 0.5); } 

.match { text-decoration: underline; 
/*
  -webkit-text-decoration-color: red;  
  text-decoration-color: red; */
    -webkit-text-decoration-line: overline underline; /* Safari */
   text-decoration-line: overline underline; 
   color:yellow;
/*   font-weight:bold; */
  
  
  } 
.LINNAEUS_only { background-color: rgba(125, 125, 125, 0.5); }
.annotated { background-color:rgba(50, 180, 180, 0.5); } 
.unannotated { background-color:rgba(214, 75, 79, 0.5); } 

.match_species { text-decoration: underline; } 
/*
ul#menu li {
/*  display:inline; 
}
.horizontal { display: inline; border-left: 3px solid darkorange; padding-left: 0.3em; }
.first { border-left: none; padding-left: 0; }
*/
ul#menu li {
list-style-type: circle;
}
table { border-collapse: collapse; } 
th, td { border: 1px solid orange; padding: 4px; } 
th {  cursor: pointer; } 
th:hover { background: yellow; }

html, body, iframe { height: 100%; }

* {
  box-sizing: border-box;
}

.row {
  display: flex;
}


/* Create two equal columns that sits next to each other */
.column {
  flex: 50%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
/* Create two equal columns that sits next to each other */
.column1 {
  flex: 30%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
/* Create two equal columns that sits next to each other */
.column2 {
  flex: 70%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
 
</style></head><body>
<h2>21183147</h2><span class="unannotated">not annotated</span> - <span class="annotated">annotated</span> - <span class="LINNAEUS_only">LINNAEUS only</span><br><hr>Antimalarial drug resistance of <span class="annotated ">Plasmodium falciparum</span> in India: changes over time and space. <br><br>After the launch of the National Malaria Control Programme in 1953, the number of malaria cases reported in India fell to an all-time low of 0*1 million in 1965. However, the initial success could not be maintained and a resurgence of malaria began in the late 1960s. Resistance of <span class="annotated ">Plasmodium falciparum</span> to chloroquine was first reported in 1973 and increases in antimalarial resistance, along with rapid urbanisation and labour migration, complicated the challenge that India's large geographical area and population size already pose for malaria control. Although several institutions have done drug-resistance monitoring in India, a complete analysis of countrywide data across institutions does not exist. We did a systematic review of <span class="annotated ">P falciparum</span> malaria drug-efficacy studies in India to summarise drug-resistance data and describe changes over the past 30 years to inform future policy. Continued use of chloroquine for treatment of <span class="annotated ">P falciparum</span> malaria in India will likely be ineffective. Resistance to sulfa-pyrimethamine should be closely monitored to protect the effectiveness of treatment with artesunate plus sulfadoxine-pyrimethamine, which is the new first-line treatment for <span class="annotated ">P falciparum</span> malaria. Strategies to reduce the emergence and spread of future drug resistance need to be proactive and supported by intensive monitoring. 
<br><br><br><hr><h3>Ann file</h3><pre>T1	Species 32 53	Plasmodium falciparum<br><br>N1	Reference T1 Taxonomy:5833<br><br>T2	Species 377 398	Plasmodium falciparum<br><br>N2	Reference T2 Taxonomy:5833<br><br>T3	Species 835 847	P falciparum<br><br>N3	Reference T3 Taxonomy:5833<br><br>T4	Species 1036 1048	P falciparum<br><br>N4	Reference T4 Taxonomy:5833<br><br>T5	Species 1288 1300	P falciparum<br><br>N5	Reference T5 Taxonomy:5833<br><br></pre></body></html>